Site Search

… that A11 acts via a distinct mechanism from existing AD therapeutics, A11 could be used alone or in combination with approved therapeutics to provide improved treatment options for …

… Prescott said. “Our hope is to use these insights to build therapeutics that could halt or reverse airway scarring, or …

… metabolomics in neurodegenerative diseases, to potential therapeutics, such as gene therapies, or sensory stimulation …

… direction, and oversees the center’s efforts to develop therapeutics for schizophrenia and other serious mental … disease Glia synaptic plasticity neurodegeneration therapeutics psychiatric disorders Broad Institute, 75 Ames … and direction, and oversee the center’s efforts to develop therapeutics for schizophrenia and other serious mental …

… for Parkinson’s disease and Down syndrome. Cognito Therapeutics, an MIT spin-off company co-founded by Tsai and …

… are new hypotheses in fields that have been wanting for therapeutics for decades,” Heiman said. “It could be that … are new hypotheses in fields that have been wanting for therapeutics for decades,” Heiman said. “It could be that …